SAP130

Across TCGA pan-cancer cohorts, SAP130 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of SAP130’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where SAP130 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types SAP130 is over-expressed in tumor.

HNSC, LSCC, and CCRCC are the cancer types where SAP130 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SAP130 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	II,III,IV	+0.161	<.001	8	view →
LSCC	Male	All	+0.182	<.001	7	view →
CCRCC	Male	All	+0.160	<.001	6	view →
COAD	Female	III,IV	+0.232	.001	1	view →
LUAD	Male	All	+0.055	.035	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

SAP130–HNSC

Open the HNSC breakdown →